Form 4 for ACRV Acrivon Therapeutics, Inc.
Accepted 2022-11-16 00:00:00 ET · period of report 2022-11-14 · accession 0001209191-22-057397 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2022-11-16 | 2022-11-14 | ACRV | Masson Kristina | EVP - Business Ops, Dir | A - Grant | $0.00 | +1.50M | 2.31M | +185% | $0 |
| D | 2022-11-16 | 2022-11-14 | ACRV | Masson Kristina | EVP - Business Ops, Dir | A - Grant | $0.00 | +26.7K | 320.7K | +9% | $0 |
| DI | 2022-11-16 | 2022-11-14 | ACRV | Masson Kristina | EVP - Business Ops, Dir | A - Grant | $0.00 | +180.3K | 180.3K | New | $0 |
| D | 2022-11-16 | 2022-11-14 | ACRV | Masson Kristina | EVP - Business Ops, Dir | A - Grant | $0.00 | +80.1K | 80.1K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-14 | A | A | 934,731 | $0.00 | 1,806,588 | I See footnote | — | — | (F3) These securities are held by Dr. Masson's spouse. Dr. Masson disclaims beneficial ownership of such securities except to the extent of her pecuniary interest therein. |
| 2 | Common | Common Stock | 2022-11-14 | A | A | 26,707 | $0.00 | 320,705 | D See footnote | — | — | (F3) These securities are held by Dr. Masson's spouse. Dr. Masson disclaims beneficial ownership of such securities except to the extent of her pecuniary interest therein. |
| 3 | Common | Common Stock | 2022-11-14 | A | A | 60,090 | $0.00 | 2,370,097 | I | — | — | |
| 4 | Common | Common Stock | 2022-11-14 | A | A | 503,419 | $0.00 | 2,310,007 | I See footnote | — | — | (F3) These securities are held by Dr. Masson's spouse. Dr. Masson disclaims beneficial ownership of such securities except to the extent of her pecuniary interest therein. |
| 5 | Derivative | Stock Option (Right to Buy) | 2022-11-14 | A | A | 180,269 | $0.00 | 180,269 | I | $12.50 · — to 2032-11-13 | 180,269 Common Stock | (F6) Twenty-five percent (25%) of the shares subject to the option shall vest on the one-year anniversary of the grant date, and the remaining shares subject to the option shall vest in 36 equal monthly installments thereafter, in each case subject to the Reporting Person's continuous service through each such vesting date. |
| 6 | Derivative | Stock Option (Right to Buy) | 2022-11-14 | A | A | 80,120 | $0.00 | 80,120 | D See footnote | $12.50 · — to 2032-11-13 | 80,120 Common Stock | (F3) These securities are held by Dr. Masson's spouse. Dr. Masson disclaims beneficial ownership of such securities except to the extent of her pecuniary interest therein. (F6) Twenty-five percent (25%) of the shares subject to the option shall vest on the one-year anniversary of the grant date, and the remaining shares subject to the option shall vest in 36 equal monthly installments thereafter, in each case subject to the Reporting Person's continuous service through each such vesting date. |